Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Image: In vivo urate spherulites in a patient with gout.
Pirker I, Nussberger M, von Kempis J. Pirker I, et al. Among authors: von kempis j. ACR Open Rheumatol. 2021 Dec;3(12):888. doi: 10.1002/acr2.11350. Epub 2021 Sep 23. ACR Open Rheumatol. 2021. PMID: 34558230 Free PMC article. No abstract available.
Important differential diagnosis in acute tenosynovitis.
Pirker IFJ, Rein P, von Kempis J. Pirker IFJ, et al. Among authors: von kempis j. BMJ Case Rep. 2019 Jan 10;12(1):bcr-2018-228373. doi: 10.1136/bcr-2018-228373. BMJ Case Rep. 2019. PMID: 30635314 Free PMC article. No abstract available.
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Mueller RB, Schulze-Koops H, Furst DE, Cohen SB, Kwok K, Wang L, Killeen T, von Kempis J. Mueller RB, et al. Among authors: von kempis j. Clin Rheumatol. 2022 Apr;41(4):1045-1055. doi: 10.1007/s10067-021-05908-z. Epub 2022 Jan 1. Clin Rheumatol. 2022. PMID: 34973077 Free PMC article.
Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study.
Mueller RB, Graninger W, Sidiropoulos P, Goger C, von Kempis J. Mueller RB, et al. Among authors: von kempis j. Clin Rheumatol. 2017 Oct;36(10):2187-2192. doi: 10.1007/s10067-017-3779-2. Epub 2017 Aug 3. Clin Rheumatol. 2017. PMID: 28776300 Clinical Trial.
72 results